Compare BVS & ULCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BVS | ULCC |
|---|---|---|
| Founded | 2011 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 982.2M | 1.1B |
| IPO Year | 2016 | 2017 |
| Metric | BVS | ULCC |
|---|---|---|
| Price | $13.63 | $6.28 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 8 |
| Target Price | ★ $14.00 | $5.21 |
| AVG Volume (30 Days) | 460.2K | ★ 2.2M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 163.46 | N/A |
| EPS | ★ 0.52 | N/A |
| Revenue | $568,087,000.00 | ★ $3,724,000,000.00 |
| Revenue This Year | $7.52 | $23.76 |
| Revenue Next Year | $7.06 | $11.48 |
| P/E Ratio | $26.25 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.26 | $3.02 |
| 52 Week High | $15.89 | $8.41 |
| Indicator | BVS | ULCC |
|---|---|---|
| Relative Strength Index (RSI) | 50.84 | 58.65 |
| Support Level | $13.44 | $5.39 |
| Resistance Level | $14.71 | $6.66 |
| Average True Range (ATR) | 0.51 | 0.23 |
| MACD | -0.08 | 0.10 |
| Stochastic Oscillator | 51.85 | 95.45 |
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos, and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. The majority of revenue is from Domestic flight follow by International.